Ticker
MRSNCompany Name
MERSANA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 80.14M | $ 59.34M | $ 20.8M |
3/31/2025 | $ 106.19M | $ 58.16M | $ 48.03M |
12/31/2024 | $ 136.9M | $ 62.46M | $ 74.45M |
9/30/2024 | $ 160.56M | $ 68.3M | $ 92.26M |
6/30/2024 | $ 168.96M | $ 62.18M | $ 106.78M |
3/31/2024 | $ 187.54M | $ 53.41M | $ 134.13M |
12/31/2023 | $ 214.06M | $ 63.64M | $ 150.42M |
9/30/2023 | $ 249.74M | $ 67.93M | $ 181.81M |
6/30/2023 | $ 297.09M | $ 74.92M | $ 222.17M |
3/31/2023 | $ 281.81M | $ 83.4M | $ 198.41M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for MERSANA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 274.93M ] - LiabilitesC [ $ 21.07M ]
(=) Working Capital [ $ 253.86M ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |